RAPT Therapeutics stock surges 63% in pre-market trade on Nasdaq after GSK’s $2.2 billion acquisition deal

RAPT Therapeutics stock surges 63% in pre-market trade on Nasdaq after GSK’s $2.2 billion acquisition deal

RAPT Therapeutics stock surges 63% in pre-market trade on Nasdaq after GSK’s $2.2 billion acquisition deal

Leave a Reply

Your email address will not be published. Required fields are marked *